Hematological Disorders in Patients With GI Angiodysplasia

Hematological Disorders in Patients With Gastrointestinal Angiodysplasia

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07183995

Enrollment

Registered

2025-09-19

Start date

2025-09-30

Completion date

2027-08-31

Last updated

2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GI Bleeding

Brief summary

The aim of this study will be to assess the association between GIT angiodysplasia with any hematological disorders as von Willebrand factor and Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

Adults (above 18 years) and elderly Both genders Admitted to GIT Unit with manifestations of GIT bleeding diagnosed by upper endoscopy and Colonoscopy as angiodyplasia. \-

Exclusion criteria

other causes of GIT bleeding \-

Design outcomes

Primary

Measure	Time frame	Description
Correlation between GIT Angiodysplasia and Hematological disorders	Baseline	All patients eligible to participate will undergo the following: 1. upper endoscopy 2. Colonoscopy 3. Complete blood count, CRP 4. D-Dimer, liver function tests, blood Urea and serum Creatinine 5. ECG 6. Coagulation profile (aPTT , von Willebrand factor activity &antigen)

Secondary

Measure	Time frame
Prevelance of different hematological disorders in angiodysplasia patients	Baseline
Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality	Baseline

Contacts

Primary ContactMennat-allah Alaa Abdelgaber, Resident

Menna.17289695@med.aun.edu.eg+201021789585

Outcome results